Navigation Links
Milestone of 3,000 USP Reference Standards
Date:3/5/2013

Rockville, MD (PRWEB) March 05, 2013

In a milestone representing a significant contribution to public health, the U.S. Pharmacopeial Convention (USP) announces that it has grown its portfolio of reference standards to now include 3,000 items. USP Reference Standards are highly characterized samples of active pharmaceutical ingredients and impurities, food chemicals, and dietary supplements and their ingredients. Regulators and manufacturers use USP Reference Standards to assess products’ conformity to standards of identity, quality, purity and strength. USP Reference Standards are specified in the monographs of the U.S. Pharmacopeia and National Formulary (USP–NF), USP’s flagship compendia of quality standards; the Food Chemicals Codex (for food ingredients), the Dietary Supplements Compendium, and the new Medicines Compendium. Drugs sold or manufactured in the United States are required by law to comply with standards published in the USP–NF, and these standards are enforceable by the Food and Drug Administration.

“Attaining 3,000 USP Reference Standards is important for USP, of course, but also for all stakeholders interested in advancing public health,” said Roger L. Williams, M.D., chief executive officer at USP. “USP relies on our volunteer experts who, with staff, set the standards, and on the manufacturers who donate the monographs and materials from which many of our standards are derived. Both are equally crucial in the standards-setting process, and I want to take this opportunity to thank all who understand the importance of public standards.”

Dr. Williams also noted USP’s focused effort over the last decade to strengthen USP’s public standards. This effort is ongoing, and is summarized in USP’s policy statements and in a stimuli article.

USP distributes thousands of units of its Reference Standards every year to customers in more than 140 countries around the world. The breadth and depth of the USP catalog means that regulators and manufacturers have the fullest available complement of publicly available standards to help ensure the quality of medicines, foods and dietary supplements throughout the supply chain, from manufacturers to practitioners, patients and consumers.

For more information, please visit http://www.usp.org/usp-nf. Media inquiries may be directed to mediarelations(at)usp(dot)org.

###

USP—Advancing Public Health Since 1820
The United States Pharmacopeial (USP) Convention is a scientific, nonprofit, standards-setting organization that advances public health through public standards and related programs that help ensure the quality, safety, and benefit of medicines and foods. USP's standards are recognized and used worldwide. For more information about USP visit http://www.usp.org.

Read the full story at http://www.prweb.com/releases/3000/ReferenceStandards/prweb10498344.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. GenVec Achieves Second Milestone in Collaboration
2. Kensey Nash Corporation Announces Achievement of $6 Million Milestone From Spectranetics Corporation
3. Start of Phase IIa Study in Acute Lung Injury Patients Marks Development Milestone
4. MacroGenics Receives Milestone Payment as Part of Its Global DART™ Alliance with Boehringer Ingelheim
5. CitiusTech Completes Another Milestone Year: Revenues Grow by 59% in 2011
6. BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals
7. AtheroNova Achieves Milestone in Initiating First Shipment of AHRO-001
8. Cobalt Technologies Hits Key Commercial Milestone with Pretreatment Process Demonstration
9. Cell Therapeutics, Inc. (CTI) Reports First Quarter Financial Results and Milestones
10. Northwest Bio and Fraunhofer IZI Announce Milestones Reached
11. A milestone in nanoparticle research: Nanoparticle test handbook sets the standards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... , ... October 11, 2017 , ... ... gene in its endogenous context, enabling overexpression experiments and avoiding the use of ... small RNA guides is transformative for performing systematic gain-of-function studies. , This ...
(Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and ... of osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and ... San Diego Rotary Club. The event entitled “Stem Cells and Their ... 300+ attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter ...
Breaking Biology Technology:
(Date:4/5/2017)... April 5, 2017  The Allen Institute for Cell ... Explorer: a one-of-a-kind portal and dynamic digital window into ... data, the first application of deep learning to create ... cell lines and a growing suite of powerful tools. ... these and future publicly available resources created and shared ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/29/2017)... the health IT company that operates the largest health ... today announced a Series B investment from BlueCross BlueShield ... investment and acquisition accelerates higi,s strategy to create the ... activities through the collection and workflow integration of ambient ... secures data today on behalf of over 36 million ...
Breaking Biology News(10 mins):